FORM SC 13D

Company

Adicet Bio, Inc.

Filed

September 24, 2020

Accession Number

0001062993-20-004636

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →